During the early stages of the coronavirus disease 2019 (COVID-19), rapid testing was imperative for public health policymakers and health care workers in order to determine where and what measures ...

Lateral flow devices, or lateral flow tests, have played a significant role in helping to identify infectious individuals during the coronavirus disease 2019 (COVID-19) pandemic. They have been key ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a recent trial. An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce ...

Lateral flow tests (LFTs) are widely used across healthcare, food safety and environmental monitoring, providing rapid, on-site results. But challenges with sensitivity, flexibility and usability ...

In what U.S. FDA commissioner Stephen Hahn billed as “a major milestone” in testing for the COVID-19 pandemic, the FDA has granted an emergency use authorization (EUA) to Ellume Ltd., of East Brisbane ...

CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its ...

ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Jabil (NYSE: JBL) today announced the next step in its manufacturing and supply chain collaboration with ams OSRAM, a global leader in optical solutions, with ...

A new survey of clinicians from 21 different countries has found a lack of consensus regarding the definition of familial amyotrophic lateral sclerosis. In addition, attitudes towards genetic testing ...

AUSTIN, Texas and TOKYO, Sept. 9, 2025 /PRNewswire/ -- "The Lateral Flow Assays Market Size was US$ 7.51 billion in 2024, with a rise of US$ 7.50 billion in 2024, and is expected to reach US$ 15.68 ...